⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure 11 from Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer

Biagio Ricciuti Arielle Elkrief Joao V. Alessi Xinan Wang Yvonne Li Hersh Gupta Daniel M. Muldoon Arrien A. Bertram Federica Pecci Giuseppe Lamberti Alessandro Di Federico Adriana Barrichello Victor R. Vaz Malini Gandhi Elinton Lee Geoffrey I. Shapiro Hyesun Park Mizuki Nishino James Lindsay Kristen D. Felt Bijaya Sharma Andrew D. Cherniack Scott J. Rodig Daniel R. Gomez Narek Shaverdian Mehrdad Rakaee Chaitanya Bandlamudi Marc Ladanyi Pasi A. Jänne Adam J. Schoenfeld Lynette M. Sholl Mark M. Awad Michael L. Cheng

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure 11. Overall survival since the date of initial diagnosis among patients with stage IV NSCLC according to ATM mutation status.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ricciuti et al. (2024) studied this question.

synapsesocial.com/papers/68e587eeb6db643587523b3c https://doi.org/10.1158/1078-0432.27031228.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 11 from Clinicopathologic, genomic, and immunophenotypic landscape of <i>ATM </i>mutations in non-small cell lung cancer2024
2Supplementary Figure 13 from Clinicopathologic, genomic, and immunophenotypic landscape of <i>ATM </i>mutations in non-small cell lung cancer2024
3Supplementary Figure 13 from Clinicopathologic, genomic, and immunophenotypic landscape of <i>ATM </i>mutations in non-small cell lung cancer2024
4Supplementary Figure 9 from Clinicopathologic, genomic, and immunophenotypic landscape of <i>ATM </i>mutations in non-small cell lung cancer2024
5Supplementary Figure 9 from Clinicopathologic, genomic, and immunophenotypic landscape of <i>ATM </i>mutations in non-small cell lung cancer2024
6Supplementary Figure 12 from Clinicopathologic, genomic, and immunophenotypic landscape of <i>ATM </i>mutations in non-small cell lung cancer2024
7Supplementary Figure 12 from Clinicopathologic, genomic, and immunophenotypic landscape of <i>ATM </i>mutations in non-small cell lung cancer2024
8Supplementary Figure 10 from Clinicopathologic, genomic, and immunophenotypic landscape of <i>ATM </i>mutations in non-small cell lung cancer2024